Skip to content

Efficacy and safety of remimazolam tosilate in peri-extubation of aortic dissection

Efficacy and safety of remimazolam tosilate in peri-extubation of aortic dissection

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073797
Enrollment
Unknown
Registered
2023-07-21
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Standford type B aortic dissection

Interventions

Control group/Propofol group :Propofol was used for sedation during periextubation
Experimental group/Remimazolam group :Remimazolam tosilate was used for sedation during periextubation

Sponsors

Department of Anesthesia and Perioperative Medicine, Jiangsu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The patient was diagnosed with Stanford type B dissection by imaging examination and the surgical type was single cardiac interventional surgery; (2) Aged 18-75, both sexes; (3) No history of alcohol addiction, or no history of alcohol consumption in the past two weeks; (4) New York College of Cardiology (NYHA) Cardiac Function Class ? or ?.

Exclusion criteria

Exclusion criteria: (1) Refuse to participate in the study; (2) Other cardiac surgery, previous cardiac surgery history, acute cardiac tamponade or myocardial infarction, severe sinus bradycardia, severe atrioventricular block or sick sinus syndrome; (3) Previous severe chronic pulmonary disease, pulse oxygen saturation <90% without oxygen inhalation; (4) Patients with Child-Pugh grade C liver function, severe liver dysfunction; (5) Patients with severe renal insufficiency requiring preoperative renal replacement therapy; (6) suffering from stroke, schizophrenia, depression, Parkinson's disease, epilepsy or dementia; (7) Unable to communicate due to language impairment or significant hearing impairment.

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure at different time points;

Secondary

MeasureTime frame
Heart rate at different time points;RASS score;Levels of inflammatory cytokines in blood at different time points;Duration of mechanical ventilation;

Countries

China

Contacts

Public ContactYu Chen

The First Affiliated Hospital of Nanjing Medical University(Jiangsu province Hospital)

chenyu_njmu@126.com+86 139 5103 3928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026